// STATE LEGISLATION TRACKER

Ohio SB 152: Allow wild animal rehab facility to get euthanasia drug permit

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Ohio
Bill: SB 152
Session: 136
Filed: 2025-03-19
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Ohio SB152 is an animal-care and pharmacy-licensing bill, not a peptide-access bill. It lets wild animal rehabilitation facilities get a limited Ohio pharmacy-board license to buy, possess, and administer approved euthanasia and pre-euthanasia drugs for animals, with no apparent change to compounded peptides, off-label prescribing, telehealth, NP or naturopath scope, FDA 503A/503B compounding, or PDMP rules.

Key Points

No apparent impact on peptide prescribing or patient access
No apparent change to compounded peptide rules
No telehealth, NP, or naturopath scope expansion
Limited drug authority applies to animal euthanasia only
Pharmacy terminology changes do not appear peptide-specific

What to Watch For

Note Ohio pharmacy-board rules may be updated for animal euthanasia drug licenses, but this is separate from peptide care.

Note The bill touches dangerous-drug licensing, but only in the narrow context of animal shelters and wildlife rehab facilities.

Where the Bill Stands

The bill has been enacted and became effective on March 4, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws